Recap: Beam Therapeutics Q2 Earnings

 

Beam Therapeutics BEAM reported its Q2 earnings results on Tuesday, August 9, 2022 at 06:00 AM.

Here's what investors need to know about the announcement.

Earnings

Beam Therapeutics beat estimated earnings by 5.56%, reporting an EPS of $-1.02 versus an estimate of $-1.08.

Revenue was up $16.65 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.31 which was followed by a 7.48% increase in the share price the next day.

 

To track all earnings releases for Beam Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

BEAM Logo
BEAMBeam Therapeutics Inc
$16.91-0.68%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
16.36
Growth
Not Available
Quality
Not Available
Value
23.25
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In:
Comments
Loading...